Celldex Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Celldex Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • Celldex Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending February 14, 2025 was 66.4M shares, a 18.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 66.4M +10.5M +18.8% Feb 14, 2025 10-K 2025-02-27
Q3 2024 66.3M +19.1M +40.4% Oct 29, 2024 10-Q 2024-11-06
Q2 2024 66.3M +19M +40.3% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 65.9M +18.7M +39.5% Apr 30, 2024 10-Q 2024-05-06
Q4 2023 55.9M +8.69M +18.4% Feb 14, 2024 10-K 2024-02-26
Q3 2023 47.3M +164K +0.35% Oct 27, 2023 10-Q 2023-11-02
Q2 2023 47.3M +488K +1.04% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 47.3M +498K +1.07% Apr 28, 2023 10-Q 2023-05-04
Q4 2022 47.2M Feb 13, 2023 10-K 2023-02-28
Q3 2022 47.1M +436K +0.93% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 46.8M +291K +0.63% Jul 29, 2022 10-Q 2022-08-08
Q1 2022 46.8M +7.14M +18% Apr 29, 2022 10-Q 2022-05-05
Q3 2021 46.7M +7.1M +17.9% Oct 31, 2021 10-Q 2021-11-09
Q2 2021 46.5M +7.36M +18.8% Jul 31, 2021 10-Q 2021-08-05
Q1 2021 39.6M +22M +125% Mar 22, 2021 10-K 2021-03-29
Q3 2020 39.6M +23.4M +145% Oct 31, 2020 10-Q 2020-11-05
Q2 2020 39.1M +24.1M +161% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 17.6M +3.81M +27.6% Mar 13, 2020 10-K 2020-03-26
Q3 2019 16.1M -156M -90.6% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 15M -147M -90.8% Jul 31, 2019 10-Q 2019-08-07
Q1 2019 13.8M -127M -90.2% Apr 30, 2019 10-Q 2019-05-07
Q3 2018 172M +36.5M +26.8% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 162M +34.1M +26.6% Jul 31, 2018 10-Q 2018-08-08
Q1 2018 141M +17.9M +14.5% Feb 28, 2018 10-K 2018-03-07
Q3 2017 136M +34.7M +34.3% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 128M +27.8M +27.6% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 123M +24.5M +24.8% Mar 6, 2017 10-K 2017-03-14
Q3 2016 101M +2.6M +2.64% Oct 31, 2016 10-Q 2016-11-07
Q2 2016 101M +1.95M +1.98% Jul 31, 2016 10-Q 2016-08-08
Q1 2016 98.7M +238K +0.24% Apr 26, 2016 10-Q 2016-05-05
Q3 2015 98.6M +9.06M +10.1% Oct 27, 2015 10-Q 2015-11-05
Q2 2015 98.6M +9.19M +10.3% Jul 28, 2015 10-Q 2015-08-10
Q1 2015 98.5M +9.12M +10.2% Apr 22, 2015 10-Q 2015-04-29
Q3 2014 89.6M +8.48M +10.5% Oct 31, 2014 10-Q 2014-11-05
Q2 2014 89.4M +8.42M +10.4% Jul 28, 2014 10-Q 2014-08-07
Q1 2014 89.4M +8.49M +10.5% Apr 22, 2014 10-Q 2014-05-01
Q3 2013 81.1M +19.1M +30.9% Oct 29, 2013 10-Q 2013-11-08
Q2 2013 81M +21.7M +36.6% Jul 29, 2013 10-Q 2013-08-06
Q1 2013 80.9M +22.1M +37.7% Apr 24, 2013 10-Q 2013-05-03
Q3 2012 62M +17.8M +40.4% Oct 30, 2012 10-Q 2012-11-02
Q2 2012 59.3M +15.1M +34.3% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 58.7M Apr 26, 2012 10-Q 2012-05-04
Q3 2011 44.1M Oct 31, 2011 10-Q 2011-11-03
Q2 2011 44.1M Aug 1, 2011 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.